RUVBL1 and YY1 promote tumor growth (Wang et al., 2015; Fan et al., 2017), and inhibiting RUVBL1 expression in metastatic breast cancer cells can reduce both cell proliferation and invasion (Fan et al., 2017). Here, YY1 is linked to neoplasm.